1. Aghion, P., Howitt, P., & Murtin, F. (2010). The relationship between health and growth: When Lucas meets Nelson-Phelps (Working Paper No. 15813). National Bureau of Economic Research.
2. Anell, A. (2004). Priority setting for pharmaceuticals. The European Journal of Health Economics, Formerly: HEPAC,
5(1), 28–35.
3. Bavisetty, S., Grody, W. W., & Yazdani, S. (2013). Emergence of pediatric rare diseases. Rare Diseases,
1, e23579.
4. Bentham, J., & Mill, J. S. (2004). Utilitarianism and other essays. UK: Penguin.
5. Brazier, J., Rowen, D., Murkuria, C., Whyte, S., Keetharuth, A., Rise Hole, A., et al. (2013). Eliciting societal preferences for burden of illness, therapeutic improvement and end of life for value based pricing: A report of the main survey. Sheffield, York: Report for the Department of Health EEPRU.